关注
Mengyao Xu
Mengyao Xu
Massachusetts General Hospital
在 mgh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers
W Xu, M Xu, L Wang, W Zhou, R Xiang, Y Shi, Y Zhang, Y Piao
Signal transduction and targeted therapy 4 (1), 55, 2019
1272019
TFAP2C-mediated lncRNA PCAT1 inhibits ferroptosis in docetaxel-resistant prostate cancer through c-Myc/miR-25-3p/SLC7A11 signaling
X Jiang, S Guo, M Xu, B Ma, R Liu, Y Xu, Y Zhang
Frontiers in oncology 12, 862015, 2022
552022
Direct reprogramming of human fibroblasts into sweat gland-like cells
Z Zhao, M Xu, M Wu, K Ma, M Sun, X Tian, C Zhang, X Fu
Cell Cycle 14 (21), 3498-3505, 2015
282015
A novel isoform of ATOH8 promotes the metastasis of breast cancer by regulating RhoC
M Xu, S Huang, X Dong, Y Chen, M Li, W Shi, G Wang, C Huang, Q Wang, ...
Journal of Molecular Cell Biology 13 (1), 59-71, 2021
182021
A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis
J Li, X Qin, J Shi, X Wang, T Li, M Xu, X Chen, Y Zhao, J Han, Y Piao, ...
Elife 10, e66222, 2021
162021
Transdifferentiation of fibroblasts by defined factors
Z Zhao, M Xu, M Wu, X Tian, C Zhang, X Fu
Cellular Reprogramming (Formerly" Cloning and Stem Cells") 17 (3), 151-159, 2015
82015
Cytotoxic lymphocytes-related gene ITK from a systematic CRISPR screen could predict prognosis of ovarian cancer patients with distant metastasis
M Xu, S Huang, J Chen, W Xu, R Xiang, Y Piao, S Zhao
Journal of translational medicine 19, 1-12, 2021
62021
Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma
Y Matoba, DT Zarrella, V Pooladanda, M Azimi Mohammadabadi, E Kim, ...
British Journal of Cancer 130 (9), 1463-1476, 2024
2024
Structural basis for antibody recognition of the proximal MUC16 ectodomain
K Lee, K Perry, M Xu, I Veillard, R Kumar, TD Rao, BR Rueda, DR Spriggs, ...
Journal of Ovarian Research 17 (1), 41, 2024
2024
Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents
TD Rao, M Xu, S Eng, G Yang, R Manson, N Rosales, R Kumar, ...
Molecular cancer therapeutics 21 (5), 775-785, 2022
2022
Transcoelomic spread of cancer cells across the peritoneal cavity occurs in most initially diagnosed ovarian cancer (OC) patients and accounts for most cancer-related death …
J Li, X Qin, J Shi, X Wang, T Li, M Xu, X Chen, Y Zhao, J Han, Y Piao, ...
eLife, 2021
2021
A systematic CRISPR screen reveals an IL-20/IL20RA-mediated peritoneal immune crosstalk to prevent the ovarian cancer metastasis
J Li, X Qin, J Shi, X Wang, T Li, M Xu, X Chen, Y Zhao, J Han, Y Piao, ...
bioRxiv, 2021.01. 03.425154, 2021
2021
The systematic identification of novel immune checkpoint averting the metastasis of ovarian cancer: The role of IL-20/IL24-IL20RA axis.
J Li, X Qin, M Xu, J Yan, L Wang, Y Shi, R Xiang
CANCER IMMUNOLOGY RESEARCH 8 (3), 110-111, 2020
2020
A Systematic CRISPR Screen Reveals an IL-20/IL20RA-Mediated Peritoneal Crosstalk to Prevent the Ovarian Cancer Metastasis
J Li, X Qin, J Shi, X Wang, T Li, M Xu, X Chen, Y Zhao, J Han, Y Piao, ...
Available at SSRN 3742250, 0
系统目前无法执行此操作,请稍后再试。
文章 1–14